Grail Inc (GRAL)

Currency in USD
33.08
-0.67(-1.99%)
Closed·
After Hours
33.080.00(0.00%)
·
GRAL Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Earnings results expected in 6 days
GRAL is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
31.9733.61
52 wk Range
12.3363.99
Key Statistics
Prev. Close
33.75
Open
33.61
Day's Range
31.97-33.61
52 wk Range
12.33-63.99
Volume
902.07K
Average Volume (3m)
1.38M
1-Year Change
96.91%
Book Value / Share
71.21
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
GRAL Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
40.50
Upside
+22.43%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Grail Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Grail Inc Company Profile

GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, it develops minimal residual disease post-diagnostic tests. The company was incorporated in 2015 and is headquartered in Menlo Park, California.

Grail Inc Earnings Call Summary for Q1/2025

  • Q1 2025 revenue up 19% YoY to $31.8M; EPS of -$3.10 beat -$4.26 forecast; stock fell 14.9% after-hours despite positive earnings
  • Net loss of $106.2M, down 51% YoY; cash burn expected to be no more than $320M in 2025; cash position at $677.9M
  • Anticipates 20-30% U.S. Gallery revenue growth in 2025; plans FDA PMA submission in H1 2026; interim PATHFINDER two data expected late 2025
  • Launched enhanced Gallery test, expanding market presence; CEO optimistic about future demand amid ongoing product development
  • Analysts maintain neutral stance; price targets $20-$32; concerns persist over continued losses despite revenue growth
Last Updated: 13/05/2025, 22:18
Read Full Transcript

Compare GRAL to Peers and Sector

Metrics to compare
GRAL
Peers
Sector
Relationship
P/E Ratio
−0.6x−1.8x−0.5x
PEG Ratio
0.03−0.110.00
Price/Book
0.5x0.9x2.6x
Price / LTM Sales
9.1x5.8x3.3x
Upside (Analyst Target)
21.6%304.6%42.8%
Fair Value Upside
Unlock49.4%6.5%Unlock

Analyst Ratings

1 Buy
3 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 40.50
(+22.43% Upside)

Earnings

Latest Release
May 13, 2025
EPS / Forecast
-3.10 / -4.26
Revenue / Forecast
31.84M / --
EPS Revisions
Last 90 days

GRAL Income Statement

People Also Watch

263.75
AVAV
-0.38%
38.60
BMNR
+15.90%
84.04
OKLO
-0.06%
174.69
ALAB
+28.88%
67.67
MP
-1.05%

FAQ

What Stock Exchange Does Grail Trade On?

Grail is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Grail?

The stock symbol for Grail is "GRAL."

What Is the Grail Market Cap?

As of today, Grail market cap is 1.21B.

What Is Grail's Earnings Per Share (TTM)?

The Grail EPS (TTM) is -58.51.

When Is the Next Grail Earnings Date?

Grail will release its next earnings report on 11 Aug 2025.

From a Technical Analysis Perspective, Is GRAL a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Grail Stock Split?

Grail has split 0 times.

How Many Employees Does Grail Have?

Grail has 1000 employees.

What is the current trading status of Grail (GRAL)?

As of 06 Aug 2025, Grail (GRAL) is trading at a price of 33.08, with a previous close of 33.75. The stock has fluctuated within a day range of 31.97 to 33.61, while its 52-week range spans from 12.33 to 63.99.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.